G-protein-coupled receptor heterodimerization modulates receptor function

Nature

Volumn 399, Issue 6737, 1999, Pages 697-700

  Jordan, Bryen A ^a   Devi, Lakshmi A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; DIMERIZATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; CLONING, MOLECULAR; COS CELLS; CYCLIC AMP; GENES, MYC; GTP-BINDING PROTEINS; LIGANDS; MICE; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA;

ANIMALIA;

EID: 0033578005     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/21441     Document Type: Article

References (30)

1. Herz, A. Opioids Vol. 1 (Springer, Berlin, 1993).
2. Miotto, K., Magendzo, K. & Evans, C. J. in The Pharmacology of Opioid Peptides (ed. Tseng, L.) 57-71 (Harwood, Singapore, 1995).
3. Kieffer, B. L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15, 615-635 (1995).
4. Hebert, T. E. & Bouvier, M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem. Cell Biol. 76, 1-11 (1998).
5. Gouldson, P. R., Snell, C. R., Bywater, R. P., Higgs, C. & Reynolds, C. A. Domain swapping in G-protein coupled receptor dimers. Protein Eng. 11, 1181-1193 (1998).
6. Maggio, R., Vogel, Z. & Wess, J. Co-expression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular cross-talk between G-protein-linked receptors. Proc. Natl Acad. Sci. USA 90, 3103-3107 (1993).
7. Monnot, C. et al. Polar residues in the transmembrane domains of the type I angiotensin II receptor are required for binding and coupling: Reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem. 271, 1507-1513 (1996).
8. BR2. Nature 396, 674-679 (1998).
9. B-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683-687 (1998).
10. B receptor. Nature 396, 679-682 (1998).
11. B receptor function. Science 283, 74-77 (1999).
12. Cvejic, S. & Devi, L. Dimerization of the delta opioid receptor; implications for a function in receptor internalization. J. Biol. Chem. 272, 26959-26964 (1997).
13. Romano, C., Yang, W. & O'Malley, K. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 171, 28612-28616 (1996).
14. Bai, M., Trivedi, S. & Brown, E. M. Dimerization of the extracellular calcium-sensing receptor on the cell surface of CaR-transfected HEK-293 cells. J. Biol. Chem. 273, 23605-23610 (1998).
15. Trapaidze, N., Keith, D. E., Cvejic, S., Evans, C. J. & Devi, L. A. Sequestration of the delta opioid receptor: Role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271, 29279-29285 (1996).
16. Keith, D. E. et al. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024 (1996).
17. Chu, P., Murray, S., Lissin, D. & von Zastrow, M. Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J. Biol. Chem. 272, 27124-27130 (1997).
18. 3H]U-69593, a highly selective ligand for the opioid K receptor. Eur. J. Pharmacol. 109, 281-284 (1985).
19. 5]enkephalin analogues with increased affinity and selectivity for δ opioid receptors. J. Med. Chem. 258, 299-303 (1990).
20. Portoghese, P. S., Lipkowski, A. W. & Takemori, A. E. Binaltrophimine and norbinaltrophimine, potent and selective K-opioid receptor antagonists. Life Sci. 40, 1287-1292 (1987).
21. Schiller, P. et al. TIPPψ: A highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 36, 3182-3187 (1993).
22. 2 opioid receptors. Proc. Natl Acad. Sci. USA 4061-4065 (1988).
23. Nock, B. in The Pharmacology of Opioid Peptides (ed. Tseng, L.) 29-56 (Harwood, Singapore, 1995).
24. Traynor, J. R. & Elliott, J. Delta opioid receptor subtypes and cross talk with mu receptors. Trends Pharmacol. Sci. 14, 84-86 (1993).
25. Zaki, P. A. et al. Opioid receptor types and subtypes: the delta receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36, 379-401 (1996).
26. Jordan, B. & Devi, L. A. Molecular mechanisms of opiate receptor signal transduction. Br. J. Anaesth. 81, 12-19 (1998).
27. Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. Endogenous opioid peptides: Multiple agonists and receptors. Nature 267, 495-499 (1977).
28. Cvejic, S., Trapaidze, N., Cyr, C. & Devi, L. A. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. J. Biol. Chem. 271, 4073-4076 (1996).
29. 50) of an enzyme reaction. Biochem. Pharmacol. 22, 3099-3102 (1973).
30. Polakiewicz, R., Schieferl, S. M., Dorner, L. F., Kansra, V. & Comb, M. J. A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J. Biol. Chem. 273, 12402-12406 (1998).